Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132
Crossref DOI link: https://doi.org/10.1136/lupus-2023-001113
Published Online: 2024-02-07
Published Print: 2024-02
Update policy: https://doi.org/10.1136/crossmarkpolicy
Burge, Daniel J
Werth, Victoria P
Boackle, Susan A
Posada, James https://orcid.org/0000-0003-3582-9612
License valid from 2024-02-07